JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SIEGMUND, O. H.
Right arrow Articles by LANDS, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SIEGMUND, O. H.
Right arrow Articles by LANDS, A. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 90, Issue 3, 254-259, 1947
Copyright © 1947 by American Society for Pharmacology and Experimental Therapeutics


THE BRONCHODILATOR ACTION OF COMPOUNDS STRUCTURALLY RELATED TO EPINEPHRINE

O. H. SIEGMUND 1, H. R. GRANGER 1, and A. M. LANDS 1

1 Pharmacological Research Laboratory, Frederick Stearns and Co., Division of Sterling Drug Inc., Detroit, Michigan

1. The bronchodilator effect of five homologues of epinephrine is described.

2. The N-isopropyl homologue, 1-(3', 4'-dihydroxyphenyl)-2-isopropylaminoethanol, was found to be the most effective bronchodilator. The removal of the alcoholic hydroxyl from the beta-carbon, to form 1-(3', 4'-dihydroxyphenyl)-2-aminoethane, resulted in a very great reduction in activity.

3. The branching of the N-alkyl group appears to markedly reduce toxicity.

4. The structural requirements important for effective bronchodilator activity are discussed.

Submitted on May 1, 1947







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1947 by the American Society for Pharmacology and Experimental Therapeutics.